Place of drug skin tests in investigating systemic cutaneous drug reactions

Drug Hypersensitivity

Volumn , Issue , 2007, Pages 366-379

  Barbaud, Annick ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65949113751     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000104214     Document Type: Chapter

References (130)

1. Barbaud A: Drug patch testing in systemiccutaneous drug allergy. Toxicology 2005; 209: 209-216.
2. Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, Faure GC, Schmutz JL, Bene MC: Theuse of skin testing in the investigationof cutaneous adverse drug reactions. BrJ Dermatol 1998; 139: 49-58.
3. Barbaud A, Gonçalo M, Bruynzeel D,Bircher A: Guidelines for performingskin tests with drugs in the investigationof cutaneous adverse drug reactions.Contact Dermatitis 2001; 45: 321-328.
4. Barbaud A, Bene MC, Faure G,Schmutz JL: Tests cutanés dans l'explorationdes toxidermies supposées demécanisme immuno-allergique. BullAcad Natle Med 2000; 184: 47-63.
5. Osawa J, Naito S, Aihara M, KitamuraK, Ikezawa Z, Nakajima H: Evaluationof skin test reactions in patients withnon-immediate type drug eruptions. J Dermatol 1990; 17: 235-239.
6. Bruynzeel DP, Van Ketel WG: Patchtesting in drug eruptions. Semin Dermatol1989; 8: 196-203.
7. Barbaud A: Tests cutanés dans l'investigationdes toxidermies: de la physiopathologieaux résultats des investigations.Thérapie 2002;57: 258-262.
8. Bruynzeel DP, Von Blomberg-van derFlier M, Scheper RJ, Van Ketel WG, DeHaan P: Penicillin allergy and the relevanceof epicutaneous tests. Dermatologica 1985; 171: 429-434.
9. Bruynzeel DP, Van Ketel WG: Skin tests in the diagnosis of maculopapular drug eruptions. Semin Dermatol 1987; 6:119-124.
10. Romano A, Di Fonso M, Pietrantonio F,Pocobelli D, Giannarini L, Del Bono A,Fabrizi G, Venuti A: Repeated patchtesting in delayed hypersensitivity toβ-lactam antibiotics. Contact Dermatitis 1993; 28: 190.
11. Barbaud A, Bene MC, Schmutz JL, Ehlinger A, Weber M, Faure GC: Role of delayed cellular hypersensitivity andadhesion molecules in maculopapular rashes induced by amoxicillin. Arch Dermatol 1997; 133: 481-486.
12. Barbaud A, Bene MC, Reichert-Penetrat,Jacquin-Petit MA, Schmutz JL, FaureGC: Immunocompetent cells and adhesionmolecules in 14 cases of cutaneousdrug reactions induced by antibiotics.Arch Dermatol 1998; 134: 1040-1041.
13. Britschgi M, Steiner UC, Schmid S,Depta JPH, Senti G, Bircher A, BurkhartC, Yawalkar N, Pichler WJ: T-cellinvolvement in drug-induced acute generalized exanthematous pustulosis.J Clin Invest 2001; 107: 1433-1441.
14. Brockow K, Romano A, Blanca M, RingJ, Pichler W, Demoly P: General considerationsfor skin test procedures in thediagnosis of drug hypersensitivity. Allergy2002; 57: 45-51.
15. Fernandez T, Torres MJ, R-Pena R,Fuentes MS, Robles S, Mayorga C, Blanca M: Decrease of selective immunoglobulinE response to amoxicillin despiterepeated administration ofbenzylpenicillin and penicillin V. ClinExp Allergy 2005; 35: 1645-1650.
16. Kleinhans M, Linzbach L, Zedlitz S,Kaufmann R, Boehncke WH: Positivepatch test reactions to celecoxib may bedue to irritation and do not correlatewith the results of oral provocation.Contact Dermatitis 2002; 47: 100-102.
17. Barbaud A, Bursztejn AC, Vernassiere C, Schmutz JL, Trechot P: Toxidermie àl'Aerius®:les patch-tests avec la desloratadine induisent des faux positifs.Ann Dermatol Vénéréol 2005; 132:S71.
18. Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL: Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45:265-268.
19. Conilleau V, Dompmartin A, Michel M,Verneuil L, Leroy D: Photoscratch testingin systemic drug-induced photosensitivity.Photodermatol PhotoimmunolPhotomed 2000; 16: 62-66.
20. Gonçalo M, Oliveira HS, Monteiro C,Clerins I, Figueiredo A: Allergic and systemic contact dermatitis from estradiol.Contact Dermatitis 1999; 40: 58-59.
21. Lammintausta K, Mäkela L, Kalimo K:Rapid systemic valacyclovir reactionsubsequent to acyclovir contact allergy.Contact Dermatitis 2001; 45: 181.
22. Ozkaya-Bayazit E, Bayazit H, Ozarmagan G: Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Dermatitis 1999; 41:185-189.
23. Alanko K, Stubb S, Reitamo S: Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-567.
24. Alanko K: Topical provocation of fixed drug eruption: a study of 30 patients. Contact Dermatitis 1994; 31: 25-27.
25. Klein CE, Trautmann A, Zillikens D, Brocker EB: Patch testing in an unusual case of toxic epidermal necrolysis. Con-tact Dermatitis 1995; 33: 448-449.
26. Barbaud A, Trechot P, Reichert-Pene-trat S, Granel F, Schmutz JL: Drug patch testing: the usefulness in testing on the most previously affected site in a systemic cutaneous adverse drug reac-tion to tetrazepam. Contact Dermatitis 2001; 44: 259-260.
27. Wilkinson DS, Fregert S, Magnusson B, Bandmann HJ, Calnan CD, Cronin E, Hjorth N, Maibach HJ, Malten KE, Meneghini CL, Pirilä V: Terminology of contact dermatitis. Acta Derm Vene-reol 1970; 50: 287-292.
28. Jonker MJ, Bruynzeel D: Anaphylactic reaction elicited by patch testing with diclofenac. Contact Dermatitis 2003;49: 114-115.
29. Romano A, Guéant-Rodriguez RM, Viola M, Amoghly F, Gaeta F, Nicolas JP, Guéant JL: Diagnosing immediate reactions to cephalosporins 2005;35:1234-1242.
30. Co Mnh HB, Bousquet PJ, Fontaine C, Kvedariene V, Demoly P: Systemic reac-tions during skin tests with -lactams: a risk factor analysis. J Allergy Clin Immunol 2006; 117: 466-468.
31. Lammintausta K, Kortekangas-Savo-lainen O: The usefulness of skin tests to prove drug hypersensitivity. Br J Der-matol 2005; 152:968-974.
32. Laxenaire MC, Moneret-Vautrin DA: Anaphylactic reactions to rocuronium. Br J Anaesth 2000; 85: 325-326.
33. Torres MJ, Sanchez-Sabate E, Alvarez J, Mayorga C, Fernandez J, Padial A, Cornejo-Garcia JA, Bellon T, Blanca M: Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004;59:219-224.
34. Rodriguez-Bada JL, Montanez MI, Tor-res MJ, Mayorga C, Canto G, Perez-Inestrosa E, Suau R, Blanca M: Skin testing for immediate hypersensitivity to lactams: comparison between two commercial kits. Allergy 2006;61:947-951.
35. Antunez C, Blanca-Lopez N, Torres MJ, Mayorga C, Perez-Inestrosa E, Montanez MI, Fernandez T, Blanca M: Immediate allergic reactions to cephalo-References 1 Barbaud A: Drug patch testing in systemic cutaneous drug allergy. Toxicolsporins: evaluation of cross-reactivity with a panel of penicillins and cephalo-sporins. J Allergy Clin Immunol 2006; 117: 404-410.
36. Romano A, Viola M, Mondino C, Pettinato R, Di Fonso M, Papa G, Venuti A,Montuschi P: Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002;129: 169-174.
37. Bernedo N, Gonzalez I, Gastaminza G,Audicana M, Fernandez E, Munoz D:Positive patch test in vancomycin allergy.Contact Dermatitis 2001; 45: 43.
38. Romano A, Di Fonso M, Papa G, Pietrantonio F, Federico F, Fabrizi G, Venuti A: Evaluation of adverse cutaneous reactions to aminopenicillins withemphasis on those manifested by maculopapularrashes. Allergy 1995; 50:113-118.
39. Wolkenstein P, Chosidow O, Flechet ML, Robbiola O, Paul M, Dume L, Revuz J, Roujeau J.C: Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996; 35: 234-236.
40. Barbaud A, Trechot P, Weber-Muller F, Ulrich G, Commun N, Schmutz JL:Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29cases with a study of cross-reactions between synergistins. Contact Dermatitis2004; 50: 22-26.
41. Menczer J, Barda G, Glezerman M,Hyat H, Brenner Y, Brickman CM,Tanai A: Hypersensitivity reaction to carboplatin. Results of skin tests.Eur J Gynaecol Oncol 1999; 20: 214-216.
42. Markman M, Zanotti K, Peterson G,Kulp B, Webster K, Belinson J: Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol 2003 15; 21: 4611-4614.
43. Leguy-Seguin V, Jolimoy G, Coudert B,Pernot C, Dalac S, Vabres P, Collet E:Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.J Allergy Clin Immunol 2007;119:726-730.
44. Brockow K, Kiehn M, Kleinheinz A,Vieluf D, Ring J: Positive skin tests in late reactions to radiographic contrast media. Allerg Immunol 1999; 31: 49-51.
45. Brockow K, Becker EW, Worret WI,Ring J: Late skin test reactions to radiocontrast medium. J Allergy Clin Immunol 1999; 104: 1107-1108.
46. Brockow K, Christiansen C, Kanny G,Clement O, Barbaud A, Bircher A, DewachterP, Gueant JL, Rodriguez Gueant RM, Mouton-Faivre C, Ring J,Romano A, Sainte-Laudy J, Demoly P,Pichler WJ ;ENDA;EAACI interest group on drug hypersensitivity: managementof hypersensitivity reactionsto iodinated contrast media. Allergy 2005; 60: 150-158.
47. Vernassiere C, Trechot P, Schmutz JL,Barbaud A: Results and negative value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis 2004; 50: 359-366.
48. Gueant-Rodriguez RM, Romano A,Barbaud A, Brockow K, Gueant JL: Hypersensitivityreactions to iodinated contrast media. Curr Pharm Des 2006;12: 3359-3372.
49. Figarella I, Barbaud A, Lecompte T,De Maistre E, Reichert-Penetrat S,Schmutz JL: Réaction cutanée d'hypersensibilité retardée avec polysensibilisation aux héparines et héparinoides.Ann Dermatol Vénéreol 2001; 128:25-30.
50. Ludwig RJ, Beier C, Lindhoff-Last E,Kaufmann R, Boehncke WH: Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003; 49: 158-159.
51. Vega JM, Blanca M, Carmona MJ, Garcia J, Claros A, Juarez C, Moya MC: Delayed allergic reactions to lactams. Four cases with intolerance to amoxicillin or ampicillin and good tolerance to penicillin G and V. Allergy 1991; 46:154-157.
52. Felix RH, Comaish JS: The value of patch and other skin tests in drug eruptions. Lancet 1974;1:1017-1019.
53. Romano A, Viola M, Mondino C, Pettinato R, di Fonso M, Papa G et al: Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002, 129: 169-174.
54. Dooms-Goossens A: Allergy to inhaled corticosteroids: a review. Am J Contact Dermatitis 1995; 6: 1-3.
55. Bircher AJ, Pelloni F, Langauer-Messmer S, Müller D: Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes. Br J Dermatol 1996; 135: 310-313.
56. Kilpio K, Hannuksela M: Corticosteroid allergy in asthma. Allergy 2003; 58: 1131-1135.
57. Buettiker U, Keller M, Pichler WJ,Braathen LR, Yawalkar N: Oral prednisolone-induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests. Dermatology 2006; 213: 40-43.
58. Bircher AJ, Flückiger R, Buchner SA:Eczematous infiltrate plaque to subcutaneous heparin: a type IV allergic reaction.Br J Dermatol 1990; 123: 507-514.
59. Moreau A, Dompmartin A, Esnault P, Michel M, Leroy D: Delayed hypersensitivity at the injection sites of a lowmolecular-weight heparin. Contact Dermatitis 1996; 34: 31-34.
60. Michel M, Dompmartin A, Szczurko C, Castel B, Moreau A, Leroy D: Eczematous-like drug eruption induced by synergistins. Contact Dermatitis 1996; 34: 86-87.
61. Vaillant L, Camenen I, Lorette G: Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 1989; 125: 299.
62. Silva R, Machado A, Brandao M, Goncalo S: Patch test diagnosis in carbamazepine erythroderma. Contact Dermatitis 1982; 8: 283-284.
63. Camarasa JG: Patch test diagnosis of exfoliative dermatitis due to carbamazepine. Contact Dermatitis 1985; 12: 49.
64. Romaguera C, Grimalt F, Vilaplana J, Azon A: Erythroderma from carbamazepine. Contact Dermatitis 1989; 20:304-305.
65. Jones M, Fernandez-Herrera J, Dorado JM, Sols M, Ruiz M, Garcia-Diez A: Epicutaneous test in carbamazepine cutaneous reactions. Dermatology 1994; 188: 18-20.
66. Rodriguez-Mosquera M, Iglesias A, Saez A, Vidal C: Patch test diagnosis of carbamazepine sensitivity? Contact Dermatitis 1991; 25: 137-138.
67. Alanko K: Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis 1993; 29: 254-257.
68. Corazza M, Mantovani L, Casetta I, Virgili A: Exfoliative dermatitis caused by carbamazepine in a patient with isolated IgA deficiency. Contact Dermatitis 1995; 33: 447.
69. Puig L, Nadal C, Fernandez-Figueras MT, Alomar A: Carbamazepine-induced drug rashes: diagnostic value of patch tests depends on clinicopathologic presentation. Contact Dermatitis 1996; 34: 435-437.
70. Lee AY, Choi J, Chey WY: Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine. Contact Dermatitis 2003; 48: 137-139.
71. Romano A, Pietrantonio F, Garcovich A, Rumi C, Bellocci F, Caradonna P, Barone C: Delayed hypersensitivity to diltiazem in two patients. Ann Allergy 1992; 69: 31-32.
72. Barbaud A, Trechot P, Gillet-Terver MN, Zannad F, Schmutz JL: Investigations allergologiques dans unetoxidermie audiltiazem (Tildiem 300 LPR).Thérapie 1993; 48: 498-499.
73. Cholez C, Trechot P, Schmutz JL, Faure G, Bene MC, Barbaud A: Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross-reactions between calcium channel blockers. Allergy 2003; 58:1207-1209.
74. Michel M, Dompmartin A, Louvet S, Szczurko C, Castel B, Leroy D: Skin reactions to hydroxyzine. Contact Dermatitis 1997; 36: 147-149.
75. Tomb RR, Lepoittevin JP, Espinassouze F, Heid E, Foussereau J: Systemic contact dermatitis from pseudoephedrine. Contact Dermatitis 1991; 24: 86-88.
76. Sanchez TS, Sanchez-Perez J, Aragues M, Garcia-Diaz A: Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test. Contact Dermatitis 2000; 42: 312-313.
77. Camarasa JG, Serra-Baldrich E: Tetrazepam allergy detected by patch test. Contact Dermatitis 1990; 22: 246.
78. Collet E, Dalac S, Morvan C, Sgro C, Lambert D: Tetrazepam allergy once more detected by patch test. Contact Dermatitis 1992; 26: 281.
79. Tomb R, Grosshans E, Defour E, Heid E: Allergic skin reaction to tetrazepam detected by patch testing. Eur J Dermatol 1993; 3: 116-118.
80. Calkin JM, Maibach H: Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993; 29: 223-233.
81. Pirker C, Misic A, Brinkmeier T, Frosch PJ: Tetrazepam drug sensitivity -usefulness of the patch test. Contact Dermatitis 2002; 47: 135-138.
82. Akiyama M, Nakada T, Sueki H, Fujisawa R, Iijima M: Drug eruption caused by non-ionic iodinated X-ray contrast media. J Acad Radiol 1998; 5:S159-S161.
83. Vernassiere C, Barbaud A, Trechot P, Weber-Muller F, Schmutz JL: Systemic acyclovir reaction subsequent to acyclovir contact allergy: Which systemic antiviral drug should then be used? Contact Dermatitis 2003; 49: 155-157.
84. Sakakibara T, Hata M, Numano K, Kawase Y, Yamanishi Tkawana S, Tsuboi N: Fixed-drug eruption caused by allylisopropylacetylurea. Contact Dermatitis 2001; 44: 189-190.
85. Gaig P, San Miguel-Moncin MM, Bartra J, Bonet A, Garcia-Ortega P: Usefulness of patch tests for diagnosing selective allergy to captopril. J Investig Allergol Clin Immunol 2001; 11: 204-206.
86. Kawada A, Aragane Y, Maeda A, Asai M, Shiraishi H, Tezuka T: Drug eruption induced by cefcapene pivoxil hydrochloride. Contact Dermatitis 2001;44: 197.
87. Verbeiren S, Morant C, Charlanne H, Ajebbar K, Caron J, Modiano P: Toxidermie due au celecoxib avec tests épicutané positif. Ann Dermatol Vénéreol 2002; 129: 203-205.
88. Machet L, Vaillant L, Dardaine V, Lorette G: Patch testing with clobazam: relapse of generalized drug eruption. Contact Dermatitis 1992; 26: 347-348.
89. Brown VL, Orton DI: Cutaneous adverse drug reaction to oral chlorphenamine detected with patch testing. Contact Dermatitis 2005; 52: 49-50.
90. Estrada JL, Alvarez Puebla MJ, Ortiz de Urbina JJ, Matilla B, Rodriguez Priet MA, Gozalo F: Generalized eczema due to codeine. Contact Dermatitis 2001; 44: 185.
91. Romano A, Pietrantonio F, Di Fonso M, Garcovich A, Chiarelli C, Venuti A, Barone C: Positivity of patch tests in cutaneous reaction to diclofenac. Allergy 1994; 49: 57-59.
92. Frouin E, Roth B, Grange A, Grange F, Tortel MC, Guillaume JC: Syndrome d'hypersensibilité à la fluindione (Préviscan). Positivité des tests épicutanés.Ann Dermatol Vénéreol 2005; 132: 1000-1002.
93. Rodriguez-Morales A, Alonso Llamazares A, Palacios Benito R, Martinez Cocera C: Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin. Contact Dermatitis 2001; 44: 255.
94. Scherer K, Bircher AJ: Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005; 5: 15-21.
95. Schmid DA, Depta JP, Pichler WJ: Tcell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 2006; 36:59-69.
96. Rebello S, Sanchez P, Vega JM, Sedano E, Sanchis ME, Asensio T, Callejo A: Hypersensitivity syndrome from isoniazid with positive patch test. Contact Dermatitis 2001; 45: 306.
97. Gonzalo-Garijo MA, de Arila D, Rodriguez-Nevado I: Generalized reaction after patch testing with metamizol. Contact Dermatitis 2001; 45:180.
98. Quinones Estevez D, Fernandez Schmitz C: Exanthema to metamizole. Allergy 2001; 56: 262-263.
99. Sasaki K, Yamamoto T, Kishi M, Yokozeki H, Nishioka K: Acute exanthematous pustular drug eruption induced by mexiletine. Eur J Dermatol 2001; 11: 469-471.
100. Antunes A, Davril A, Trechot P, Grandidier M, Truchetet F, Cuny JF: Syndrome d'hypersensibilité à la minocycline. Ann Dermatol Vénéreol 1999;126: 518-521.
101. Malheiro D, Cadinha S, Rodrigues J, Vaz M, Castel-Branco MG: Nimesulide-induced fixed drug eruption. Allergol Immunopathol (Madr) 2005; 33:285-287.
102. Barranco R, Tornero P, De Barrio M, De Frutos C, Rodriguez A, Rubio M: Type IV hypersensitivity to oral nystatin. Contact Dermatitis 2001; 45: 60.
103. Mashiah J, Brenner S: A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol 2003;139: 1181-1183.
104. Montoro J, Diaz M, Genis C, Lozano A, Bertomeu F: Non-pigmenting cutaneous-mucosal fixed drug eruption due to piroxicam. Allergol Immunopathol 2003; 31: 53-55.
105. Wong DA, Freeman S: Cutaneous allergic reaction to intramuscular vitamin K 1 . Australas J Dermatol 1999;40:147-152.
106. Antunez C, Martin E, Cornejo-Garcia JA, Blanca-Lopez N, R-Pena R, Mayorga C, Torres MJ, Blanca M: Immediate hypersensitivity reactions to penicillins and other -lactams. Curr Pharm Des 2006; 12: 3327-3333.
107. Bonadonna P, Schiappoli M, Senna G,Passalacqua G: Delayed selective reaction to clavulanic acid: a case report. J Investig Allergol Clin Immunol 2005;15: 302-304.
108. Torres MJ, Romano A, Mayorga C, Moya MC, Guzman AE, Reche M et al: Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001;56: 850-856.
109. El-Qutob D, Morales C, Pelaez A: Allergic reaction caused by articaine. Allergol Immunopathol (Madr) 2005; 33: 115-116.
110. Berkun Y, Ben-Zvi A, Levy Y, Galili D, Shalit M: Evaluation of adverse reactions to local anesthetics: experience with 236 patients. Ann Allergy Asthma Immunol 2003; 91: 342-345.
111. Notman MJ, Phillips EJ, Knowles SR, Weber EA, Shear NH: Clindamycin skin testing has limited diagnostic potential. Contact Dermatitis 2005; 53: 335-338
112. Padial A, Posadas S, Alvarez J, Torres MJ, Alvarez JA, Mayorga C, Blanca M: Nonimmediate reactions to systemic corticosteroids suggest an immuno-logical mechanism. Allergy 2005; 60: 665-670.
113. Caceres Calle O, Fernandez-Benitez M: Allergy to dexchlorpheniramine. Study of a case. Allergol Immuno-pathol (Madr) 2004; 32: 306-309.
114. Beaudouin E, Kanny G, Blanloeil Y, Guilloux L, Renaudin JM, Moneret-Vautrin DA: Anaphylactic shock in-duced by gadoterate meglumine (Dot-arem). Allerg Immunol (Paris) 2003; 35: 382-385.
115. Adachi A, Fukunaga A, Horikawa T: A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin. Int J Dermatol 2004; 43: 597-599.
116. Lee AY, Chey WY, Choi J, Jeon JS: In-sulin-induced drug eruptions and reliability of skin tests. Acta Derm Venereol 2002; 82: 114-117.
117. Takahama H, Tsutsumi Y, Kubota Y: Anaphylaxis due to levofloxacin. Int J Dermatol 2005; 44: 789-790.
118. Buergin S, Scherer K, Hausermann P, Bircher AJ: Immediate hypersensitiv-ity to rifampicin in three patients: diagnostic procedures and induction of clinical tolerance. Int Arch Allergy Immunol 2006; 140: 20-26.
119. Strauss RM, Green ST, Gawkrodger DJ: Rifampicin allergy confirmed by an intradermal test, but with a nega-tive patch test. Contact Dermatitis 2001; 45: 108.
120. Patel VJ, Bruck MC, Katz BE: Hyper-sensitivity reaction to hyaluronic acid with negative skin testing. Plast Re-constr Surg 2006;117:92e-94e
121. Fays S, Trechot P, Schmutz JL, Cuny JF, Truchetet F, Barbaud A: Bupropion and generalized acute urticaria: eight cases. Br J Dermatol 2003; 148: 177-178.
122. Trujillo MJ, de Barrio M, Rodriguez A, Moreno-Zazo M, Sanchez I, Pelta R, Tornero P, Herrero T: Piroxicam-induced photodermatitis. Cross-reac-tivity among oxicams. A case report. Allergol Immunopathol (Madr) 2001; 29: 133-136.
123. Gonçalo M, Figueiredo A: Cross-reac-tions among oxicams in cutaneous adverse drug reactions. Contact Der-matitis 2002; 46:s31.
124. Barranco R, Rodriguez A, de Barrio M, Trujillo MJ, de Frutos C, Matheu V, Tornero P, Herrero T: Sympathomi-metic drug allergy: cross-reactivity study by patch test. Am J Clin Derma-tol 2004, 5: 351-355
125. Lee AY, Choi J, Chey WY: Patch test-ing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine. Contact Dermatitis 2003; 48: 137-139.
126. Romano A, Quaratino D, Papa G, Di Fonso M, Venuti A: Aminopenicillin allergy. Arch Dis Child. 1997; 76: 513-517.
127. Torres MJ, Mayorga C, Leyva L, Guz-man AE, Cornejo-Garcia JA, Juarez C, Blanca M: Controlled administration of penicillin to patients with a posi-tive history but negative skin and spe-cific serum IgE tests. Clin Exp Allergy 2002; 32: 270-276.
128. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P: Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004 15;140: 1001-1006.
129. Demoly P, Benahmed S, Sahla H, Messaad D, Valembois M, Godard P, Michel FB, Bousquet J: Allergy to macrolides. 21 cases. Presse Méd 2000;29: 294-298.
130. Ulrich G, Schmutz JL, Trechot P, Commun N, Barbaud A: Sensitization to petrolatum: an unusual cause of false-positive drug patch tests. Allergy 2004; 59: 1006-1009.